NP47725a Emicizumab (Indication Specific)
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)contractFind a Tender ↗Ref ocds-h6vhtk-059d3832014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
1
Lots
1
1 awarded
Published
27 Oct 2025
Other contracts from The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)· 10
Most recent notices published by the same contracting authority.
| Title | Type | Value | Published |
|---|---|---|---|
| Information Technology Service Management | contract | — | 08 May 2026 |
| Patient Carer Online Feedback Service | contract | — | 08 May 2026 |
| NP49425 Generic and Biosimilar Transition Medicines | contract | — | 30 Mar 2026 |
| NP884925 Adobe Licence | contract | — | 27 Mar 2026 |
| Automated AST & Bacteria Testing | contract | — | 27 Mar 2026 |
| Sampling & Measuring Products | contract | — | 25 Mar 2026 |
| NP90726l Tildrakizumab (Ilumetri®) | contract | — | 17 Mar 2026 |
| Ophthalmology Equipment | contract | £8.0m | 11 Mar 2026 |
| Insulin Infusion Pumps, Continuous Glucose Monitoring Systems and Associated Consumables | contract | £100.0m | 11 Mar 2026 |
| Single Use Podiatry Instruments | contract | £2.0m | 11 Mar 2026 |
Other contracts awarded to Roche Products Ltd· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 26 Feb 2026 |
| NP90425 Faricimab (Vabysmo®) | contract | — | 11 Feb 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 14 Jan 2026 |
| NHS National Framework for the supply of Tocilizumab Injection | contract | — | 30 Dec 2025 |
| NHS National Framework for the supply of Tocilizumab Injection | contract | — | 27 Nov 2025 |
| Baloxavir Marboxil Xofluza Antiviral | contract | — | 10 Oct 2025 |
| NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 | contract | — | 01 Aug 2025 |
| NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | contract | £47.0m | 29 Jul 2025 |
| NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National | contract | £9.4m | 24 Jul 2025 |
| Biologic and Biosimilar Medicines | contract | — | 21 May 2025 |